| FRNRX | MAGRX | FRNRX / MAGRX | |
| Total Expense Ratio | 1.00 | 0.91 | 110% |
| Annual Report Gross Expense Ratio | 1.01 | 0.91 | 111% |
| Fund Existence | 31 years | 37 years | - |
| Gain YTD | 29.330 | 20.847 | 141% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 1000 | 2000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 391M | 160M | 244% |
| Annual Yield % from dividends | 1.90 | 2.39 | 79% |
| Returns for 1 year | 30.34 | 20.93 | 145% |
| Returns for 3 years | 34.16 | 9.98 | 342% |
| Returns for 5 years | 133.90 | 42.86 | 312% |
| Returns for 10 years | 91.81 | 14.75 | 623% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| GEMWX | 15.15 | 0.10 | +0.66% |
| Goldman Sachs Emerging Mkt Eq ex. Chn R6 | |||
| RSIRX | 14.66 | 0.02 | +0.14% |
| Victory RS International R6 | |||
| PRIDX | 75.33 | 0.10 | +0.13% |
| T. Rowe Price International Discovery | |||
| RLCAX | 8.70 | N/A | N/A |
| Columbia Disciplined Value A | |||
| ETAHX | 50.95 | -0.39 | -0.76% |
| Eventide Healthcare & Life Sciences A | |||